bli-801
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00583154)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bli801
- bli-801
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02822508 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2016 | Braintree Laboratories |
| NCT02820714 | Phase 2 | Feb 1, 2016 | Braintree Laboratories |
| NCT01687985 | Phase 2 | Aug 1, 2012 | Braintree Laboratories |
| NCT01301781 | Phase 2 | Jan 1, 2011 | Braintree Laboratories |
| NCT00583154 | Phase 2 | Oct 1, 2007 | Braintree Laboratories |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Braintree Laboratories | For profit | 5 | 5 | 2 | 2007 |
1 organizations
Page 1 / 1